Centile Bioscience
PrivateLast Round
Seed Round
Apr 16, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Centile Bioscience is a healthcare technology company that enables data-driven diagnosis, patient insights, and therapeutic development for brain diseases and disorders by transforming MRI and CT scans into quantitative biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centile Bioscience Comparables
Compare Centile Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qynapse | 86% | |
| Brainreader | 84% | |
| Quibim | 83% | |
Centile Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 16, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
$3M seed round completed.
Centile Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centile Bioscience's valuation, stock price, and market status.